• Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald

    Источник: Buzz FX / 07 ноя 2024 07:56:17   America/New_York


    Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) was upgraded by investment
    Read more...
Опубликовать